Melanie is the go-to Canadian litigation adviser for a wide array of world-leading clients. Her diverse intellectual property and commercial litigation practice encompasses patent, trademark, complex commercial, class actions, product liability, regulatory and technology disputes.
Melanie excels at litigating cases in emerging fields. She was counsel in the first biologic and the first biosimilar drug patent cases in Canada in addition to numerous precedent-setting trials, applications and appeals. She works extensively with life sciences companies on complex litigation of all sorts and is intimately familiar with the business of pharma and biotech. In particular, she has extensive experience leading litigation under the Patented Medicines (Notice of Compliance) Regulations. Melanie also has broad expertise in the software, technology and social media spaces, dealing with commercial, patent, trademark, copyright and licensing disputes. She leverages her unique experiences to handle a wide variety of complex commercial disputes, adeptly devising strategic options and navigating cross-border issues.
Melanie has been consistently recognized as a leading litigator both in Canada and globally. She was named the Canadian IP Litigator of the Year (2022 and 2023) and one of the Top 50 Women Litigators in Canada for several years by Benchmark; as a Rising Star: Leading Lawyers Under 40 by Lexpert as well as in multiple categories and special editions; as one of the Top 250 Women in IP worldwide by Managing Intellectual Property IP Stars (one of only a few Canadians recognized); and in all major directories, including Chambers.
